Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
M HussainD C Smith

Abstract

To determine the efficacy and toxicity of the drug combination of carboplatin, paclitaxel, and gemcitabine in patients with advanced urothelial carcinoma. Patients eligible included those with advanced urothelial malignancy of any histology, no previous chemotherapy for metastatic disease, Southwest Oncology Group performance status of 2 or less, serum creatinine levels of 2 mg/dL or less, and adequate bone marrow and hepatic function. Treatment consisted of paclitaxel 200 mg/m2, carboplatin (target area under the curve = 5) on day 1, and gemcitabine 800 mg/m2 on days 1 and 8, repeated every 21 days. Forty-nine patients (44 men and five women) were enrolled; the patients' median age was 63 years, and their median creatinine clearance was 78 mL/min (range, 26 to 165 mL/min). Forty-three patients had transitional cell carcinoma, and six had squamous cell carcinoma or mixed histology. Ten patients had metastases to lymph nodes only, six had locally advanced disease, four had locally recurrent disease, 24 patients had visceral metastases, and five had soft tissue metastases. Twenty-one patients had disease in one site, 16 in two sites, and 12 in three sites. A total of 272 cycles were administered (median, six cycles; range, 1 to 1...Continue Reading

References

Jul 11, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P J LoehrerB A Lowe
Jun 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C J LogothetisR G Kilbourn
Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A H CalvertE Wiltshaw
Nov 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B J RothP J Loehrer
Jan 1, 1993·Cancer Treatment Reviews·J Waxman, C Barton
Nov 18, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W M StadlerF A Dorr
Dec 13, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J MooreN Murray
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D J VaughnA Wein
May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B G RedmanM Hussain
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F BajorinM G Boyle
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J MooreL Seymour
Jan 22, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H von der MaaseL Dogliotti
Mar 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R DreicerG Wilding
Apr 28, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D KaufmanW Stadler
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E J SmallE D Crawford
Sep 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BellmuntJ Baselga

❮ Previous
Next ❯

Citations

Mar 5, 2002·British Journal of Cancer·X Garcia del MuroJ R Germá
Aug 31, 2004·Japanese Journal of Clinical Oncology·Taiji TsukamotoNaoya Masumori
Oct 13, 2006·World Journal of Urology·Fabio Calabrò, Cora N Sternberg
Dec 12, 2007·BJU International·Chia-Chi LinNicholas J Vogelzang
Mar 13, 2008·Dalton Transactions : an International Journal of Inorganic Chemistry·Xiaoyong Wang, Zijian Guo
Jun 23, 2009·Drugs·Neeraj Agarwal, Maha Hussain
Jan 25, 2014·International Journal of Urology : Official Journal of the Japanese Urological Association·Terence T SioUzair B Chaudhary
Aug 13, 2002·Current Opinion in Urology·Fabio Calabrò, Cora N Sternberg
Dec 17, 2004·Pediatric Blood & Cancer·John J StrouseDavid M Loeb
Mar 25, 2006·Future Oncology·L ToschiF Cappuzzo
Sep 21, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Hiroshi AokiYoichi Arai
Dec 27, 2005·Expert Review of Anticancer Therapy·Camillo F Pollera, Fabrizio Nelli
Jul 2, 2011·BJU International·Michael D ShelleyMalcolm D Mason
Oct 18, 2018·International Journal of Molecular Sciences·Se Hyun KimSun Young Rha
Aug 12, 2005·Current Opinion in Urology·Joon-ha OkChristopher P Evans
Jun 10, 2006·Expert Review of Anticancer Therapy·Arlene Siefker-Radtke
Aug 12, 2005·Current Opinion in Urology·Karen Giselle CheePrimo N Lara
Dec 22, 2007·Expert Review of Anticancer Therapy·Guru SonpavdeThomas E Hutson
Sep 6, 2006·The Journal of Urology·Wassim KassoufAshish M Kamat
Nov 23, 2011·Nature Reviews. Urology·Steve Nicholson
Jul 17, 2008·Expert Opinion on Pharmacotherapy·Guru SonpavdeSeth P Lerner
Nov 27, 2007·Expert Opinion on Pharmacotherapy·Fadi El Karak, Aude Flechon
Nov 18, 2008·Expert Opinion on Investigational Drugs·Alexandros LekasAndreas C Lazaris
Nov 30, 2005·The Oncologist·Matthew D Galsky
May 2, 2009·Current Treatment Options in Oncology·Ulka Vaishampayan
Aug 8, 2008·Current Opinion in Supportive and Palliative Care·Fabio Calabrò, Cora N Sternberg
Apr 15, 2011·The Cochrane Database of Systematic Reviews·Mike ShelleyMalcolm Mason
Mar 25, 2011·International Journal of Clinical Oncology·Hiroshi TsurutaTomonori Habuchi
Jul 25, 2014·Current Oncology Reports·Estrella M Carballido, Jonathan E Rosenberg
Dec 21, 2004·Expert Review of Anticancer Therapy·Umberto BassoSilvio Monfardini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.